PSA Response to Lenalidomide Therapy in a Pre-Treated Patient with Metastatic Prostate Cancer Refractory to Hormones and Chemotherapy: A Case Report

Publisher： Karger

E-ISSN： 1662-6575|5|1|181-186

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.5, Iss.1, 2012-04, pp. : 181-186

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metastatic Castration-Resistant Prostate Cancer: Two Case Reports of Dramatic Response with Abiraterone Acetate in Patients Heavily Pretreated with Chemotherapy

By  

Case Reports in Oncology, Vol. 6, Iss. 2, 2013-06 ,pp. : 325-330

Karger

Access to resources Recommend Favorite

PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient: A Case Report

By  

Case Reports in Oncology, Vol. 2, Iss. 1, 2009-04 ,pp. : 72-76

Karger

Access to resources Recommend Favorite

A Case Report of Metastatic Breast Cancer Treated with Korean Medicine Therapy as a Substitute for Chemotherapy

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-01 ,pp. : 27-36

Karger

Access to resources Recommend Favorite

Korean Medicine Therapy as a Substitute for Chemotherapy for Metastatic Breast Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-02 ,pp. : 64-71

Karger

Access to resources Recommend Favorite

PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient

By  

Oncology Research and Treatment, Vol. 33, Iss. 1-2, 2010-01 ,pp. : 57-59

Karger

Access to resources Recommend Favorite